Basel
Switzerland
3
2020-08-27
3
2021-04-20
These are the the leading inventors for applications assigned to Rhizen Pharmaceuticals SA:
Rhizen Pharmaceuticals SA based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Selective PI3K delta inhibitors
#2 | 2019-09-19 ✅ Patent 11,020,399 granted on 2021-06-01Intermediates useful in the synthesis of compounds as modulators of protein kinases
#3 | 2018-03-15 ✅ Patent 11,066,402 granted on 2021-07-203,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
Also check out Rhizen Pharmaceuticals SA's (Basel, Switzerland) applicant profile with 1 patent applications submitted.
587691 ⎘